Page last updated: 2024-08-25

ropivacaine and Lymphoma, T-Cell

ropivacaine has been researched along with Lymphoma, T-Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauer, I; Braun, S; Fazeli, S; Hermanns, H; Hollmann, MW; Stevens, MF; Werdehausen, R1

Other Studies

1 other study(ies) available for ropivacaine and Lymphoma, T-Cell

ArticleYear
Lipophilicity but not stereospecificity is a major determinant of local anaesthetic-induced cytotoxicity in human T-lymphoma cells.
    European journal of anaesthesiology, 2012, Volume: 29, Issue:1

    Topics: Amides; Anesthetics, Local; Apoptosis; Bupivacaine; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Inhibitory Concentration 50; Jurkat Cells; Lymphoma, T-Cell; Microscopy, Fluorescence; Necrosis; Ropivacaine; Stereoisomerism; Structure-Activity Relationship

2012